These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21506193)

  • 1. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model.
    Zarkin GA; Cowell AJ; Hicks KA; Mills MJ; Belenko S; Dunlap LJ; Houser KA; Keyes V
    Health Econ; 2012 Jun; 21(6):633-52. PubMed ID: 21506193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating the drug-abusing offender.
    Leukefeld C; Matthews T; Clayton R
    J Ment Health Adm; 1992; 19(1):76-82. PubMed ID: 10171038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance abuse prevention and treatment within the criminal justice system: an overview of the issues.
    Campbell-Heider N; Baird C
    J Addict Nurs; 2012 Feb; 23(1):7-13. PubMed ID: 22468655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forensic assertive community treatment: preventing incarceration of adults with severe mental illness.
    Lamberti JS; Weisman R; Faden DI
    Psychiatr Serv; 2004 Nov; 55(11):1285-93. PubMed ID: 15534018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.
    Krebs E; Urada D; Evans E; Huang D; Hser YI; Nosyk B
    Addiction; 2017 May; 112(5):838-851. PubMed ID: 27981691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of a prerelease substance abuse treatment program for repeat criminal offenders.
    French MT; Fang H; Fretz R
    J Subst Abuse Treat; 2010 Jan; 38(1):31-41. PubMed ID: 19631489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery-oriented care for drug-abusing offenders.
    Heaps MM; Lurigio AJ; Rodriguez P; Lyons T; Brookes L
    Addict Sci Clin Pract; 2009 Apr; 5(1):31-6. PubMed ID: 19369917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dual diagnosis on healthcare and criminal justice costs after release from Queensland prisons: a prospective cohort study.
    Snow KJ; Petrie D; Young JT; Preen DB; Heffernan E; Kinner SA
    Aust J Prim Health; 2022 Jun; 28(3):264-270. PubMed ID: 35512815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Opportunities to Improve the Health of People Involved in the Criminal Justice System in the United States.
    Freudenberg N; Heller D
    Annu Rev Public Health; 2016; 37():313-33. PubMed ID: 26789388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.
    Bernard CL; Rao IJ; Robison KK; Brandeau ML
    PLoS Med; 2020 Oct; 17(10):e1003239. PubMed ID: 33048929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia.
    Ascher-Svanum H; Nyhuis AW; Faries DE; Ball DE; Kinon BJ
    BMC Psychiatry; 2010 Jan; 10():11. PubMed ID: 20109170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking the addictive cycle of the system: improving US criminal justice practices to address substance use disorders.
    Kopak AM
    Int J Prison Health; 2015; 11(1):4-16. PubMed ID: 25751703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Treatment Accessed through the Criminal Justice System: Participants' Perspectives and Uses.
    Rosenberg A; Heimer R; Keene DE; Groves AK; Blankenship KM
    J Urban Health; 2019 Jun; 96(3):390-399. PubMed ID: 30191511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring collaboration and integration activities in criminal justice and substance abuse treatment agencies.
    Fletcher B; Lehman W; Wexler H; Melnick G; Taxman F; Young D
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S54-S64. PubMed ID: 20088023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Road Not Taken: substance abuse programming in the New York City jail system.
    Selling D; Lee D; Solimo A; Venters H
    J Correct Health Care; 2015 Jan; 21(1):7-11. PubMed ID: 25403463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment aftercare in the criminal justice system: a systematic review.
    Pelissier B; Jones N; Cadigan T
    J Subst Abuse Treat; 2007 Apr; 32(3):311-20. PubMed ID: 17383555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among state and local organizational contexts: Use of evidence-based practices in the criminal justice system.
    Henderson CE; Young DW; Farrell J; Taxman FS
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1(Suppl 1):S23-32. PubMed ID: 19174321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
    Friedmann PD; Hoskinson R; Gordon M; Schwartz R; Kinlock T; Knight K; Flynn PM; Welsh WN; Stein LA; Sacks S; O'Connell DJ; Knudsen HK; Shafer MS; Hall E; Frisman LK;
    Subst Abus; 2012; 33(1):9-18. PubMed ID: 22263709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid Enrollment among Prison Inmates in a Non-expansion State: Exploring Predisposing, Enabling, and Need Factors Related to Enrollment Pre-incarceration and Post-Release.
    Grodensky CA; Rosen DL; Blue CM; Miller AR; Bradley-Bull S; Powell WA; Domino ME; Golin CE; Wohl DA
    J Urban Health; 2018 Aug; 95(4):454-466. PubMed ID: 29934825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizational context, systems change, and adopting treatment delivery systems in the criminal justice system.
    Taxman FS; Henderson CE; Belenko S
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S1-6. PubMed ID: 19423241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.